
|Videos|October 6, 2017
What Were the Top-line Data Results from the LEAP-1 Study?
Author(s)Contagion® Editorial Staff
Steven Gelone, PharmD, shares the topline data yielded from the LEAP-1 study.
Advertisement
Steven Gelone, PharmD, chief scientific officer at Nabriva Therapeutics, shares the topline data yielded from the LEAP-1 study.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Ethiopia Investigates Marburg Virus Disease Outbreak
2
Scynexis Collaborates With Hackensack Meridian CDI, Johns Hopkins to Develop Therapeutics for Drug-Resistant Fungal Infections
3
Top Infectious Disease News Stories Week of November 22 - November 28
4
HIV Drug Resistance Declines in the Modern ART Era
5

















































































































































































































































































